Orencia 250 mg lyophilized powder for injection Images
Generic Name: abatacept
This medication has been identified as Orencia 250 mg lyophilized powder for injection. It is supplied by Bristol-Myers Squibb Company.
Orencia is used in the treatment of Rheumatoid Arthritis; Psoriatic Arthritis; Graft Versus Host Disease - Prophylaxis; Polyarticular Juvenile Idiopathic Arthritis and belongs to the drug classes antirheumatics, selective immunosuppressants. Risk cannot be ruled out during pregnancy. Orencia 250 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Orencia
- Generic Name
- abatacept
- Strength
- 250 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Antirheumatics, Selective immunosuppressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb Company
- National Drug Code (NDC)
- 00003-2187
More about Orencia (abatacept)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (70)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
- Orencia drug information
- Orencia (Abatacept Auto-Injectors)
- Orencia (Abatacept Infusion)
- Orencia (Abatacept Prefilled Syringes)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
